Join Jim Cramer as he rings the lightning round bell and answers callers’ stock questions at rapid speed. Here’s what he has to say about some of this year’s top performers.
HubSpot: A mini-Salesforce with incredible growth that people love again. Expect a rally from here.
Albemarle: Lithium prices are coming down and won’t reverse – not the right place to be.
Chewy: Bottoming out, but not much upside. People can get the stuff from Amazon.
Leonardo DRS: Great prospects ahead.
New York Community Bancorp: Even with lower rates, it’s a tough environment – not a wise investment.
Brown-Forman: A good company, but potential GLP-1 trial for heavy drinkers could affect stock.
Sarepta Therapeutics: Losing a lot of money, not a promising opportunity.
C3.ai: Not delivering, losing a fortune. Too much hype and hope there – not recommended.
US Bancorp: A safe choice among regional banks – good investment.
CrowdStrike: An incredible performer with strong potential – backed by George Kurtz for continued success.
